MS
Mani Subramanian
CEO of OrsoBio
San Francisco Bay Area
Overview
Mani Subramanian is the Founder of OrsoBio in the San Francisco Bay Area, currently serving as CEO. With a background including roles as Senior Vice President at Gilead Sciences and Executive Director at Human Genome Sciences, he brings extensive experience in leading teams and driving innovation in the biotech and healthcare sectors.
Work Experience
CEO
2020 - Current
OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.
Raised $129,300,000.00 from Ascenta Capital, Woodline Partners, Samsara BioCapital, NuevaBio, Eli Lilly, Enavate Sciences and Longitude Capital.
Senior Vice President, Liver Diseases TA Head
2011 - 2020
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Raised $4,413,500,000.00 from Abingworth.
Executive Director, Clinical Research, Infectious Diseases and Immunology
2002 - 2010
Senior Staff Scientist
2000 - 2002
Genotyping for Infections diseases
Education
Fellowship Infectious Diseases
1997 - 2000
Residency Internal Medicine
1994 - 1997
Doctor of Philosophy - PhD
1990 - 1994
Doctor of Medicine - MD
1984 - 1990